CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed
Drug / intervention
escitalopramdrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00162968
NCT00162968Phase 4Completed
CompareCT.gov

Escitalopram as a Treatment for Pain in Polyneuropathy. A Double-Blind, Randomized, Placebo Controlled Trial.

Odense University Hospital·interventional·Posted Sep 13, 2005·Updated Apr 24, 2007

In Brief

A Phase 4 clinical trial evaluating escitalopram for Pain and Polyneuropathies. Completed, across 2 sites.

Detailed Summary

Many people with polyneuropathy suffer from pain which is difficult to treat. Escitalopram is a relatively new drug used in the treatment of depression. Escitalopram's action mechanism on the brain suggests that escitalopram also may have an effect on neuropathic pain. This study will test the efficacy of escitalopram in patients with painful polyneuropathy.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPain, Polyneuropathies
CountriesDenmark
CollaboratorsAarhus University Hospital, H. Lundbeck A/S

Timeline

Phase 4CompletedFinished
20052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedSep 13, 2005
Enrollment StartDec 1, 2004
Study CompletionApr 1, 2007
TodayJul 2, 2026
Posted 20.8 years ago

Interventions

escitalopramdrug